Skip to main content

Pediatric type 2 diabetes

medwireNews

02-03-2023 | Empagliflozin | News

DINAMO: Empagliflozin shows promise for young people with type 2 diabetes

Empagliflozin, but not linagliptin, provides “clinically relevant” improvements in glycemic control versus placebo in children and adolescents with type 2 diabetes, report the DINAMO investigators.

12-19-2022 | Early onset | News

Global type 2 diabetes burden increasing in adolescents and young adults

The incidence and burden of type 2 diabetes in young people aged 15–39 years are increasing worldwide, show data from the Global Burden of Disease Study.

11-22-2022 | Dulaglutide | News

FDA clears dulaglutide for adolescents

Click through to read more on this announcement

09-23-2022 | EASD 2022 | Conference coverage | News

Childhood body size modifies diabetes risk in adulthood

The highest risk for type 2 diabetes occurs in people who progress from a low body size in childhood to a high body size in adulthood, shows an analysis of data from the UK Biobank.

Weekly pill container

04-04-2022 | Dapagliflozin | News

Phase 3 trial supports dapagliflozin in young people with type 2 diabetes

The first phase 3 trial of an SGLT2 inhibitor in children and young people with type 2 diabetes shows that dapagliflozin significantly improves their glucose control – as long as they remember to take it.

11-15-2021 | Transitions of care | News

Acute diabetes complications rise during transition to adult care

Young people with type 1 diabetes are at increased risk for hospitalization for acute complications at the time of transition from pediatric to adult care, say researchers.

10-29-2021 | Retinopathy | News

Sight-threatening retinopathy an early risk for youth-onset type 2 diabetes

Almost half of people diagnosed with type 2 diabetes in childhood develop retinopathy by their mid-20s, show TODAY2 data.

08-24-2021 | Children | News

Diabetes rates still rising in US children

Rates of both type 2 and type 1 diabetes continue to rise in US children, show data from the SEARCH registry.

Young person injecting medicine

07-28-2021 | Complications | News

Complications ‘accumulate rapidly’ in youth-onset type 2 diabetes

The risk for diabetes-related complications increases over time among people with youth-onset type 2 diabetes, with the majority having at least one microvascular complication by the time of young adulthood, suggest follow-up results from the TODAY study.

06-26-2021 | ADA 2021 | Conference coverage | News

Maternal diabetes linked to poor type 2 diabetes outcomes in children

Maternal history of diabetes is associated with accelerated loss of glycemic control and an increased risk for adverse outcomes among youth with type 2 diabetes, suggests an analysis of data from the TODAY trial.

01-12-2021 | Adolescents | News

Obesity flags high-risk cardiorenal profile in youth with type 1 diabetes

Adolescents with type 1 diabetes who are obese have a cardiorenal risk profile similar to that of their peers with type 2 diabetes, say researchers.

09-07-2020 | Bone health | News

Type 2 diabetes adversely affects bone mass in youth

Youth with type 2 diabetes have lower areal bone mineral density than those with obesity or who are of normal weight, according to the results of a cross-sectional study.

06-16-2020 | ADA 2020 | Conference coverage | News

Glycemic control not improving in youth and young adults with diabetes

Glycemic control in youth and young adults with diabetes has not improved with time, and in some cases has worsened, despite more aggressive glycemic targets and increased availability of newer diabetes technology and therapies, shows the SEARCH for Diabetes in Youth Study.

06-14-2020 | ADA 2020 | Conference coverage | News

Diastolic dysfunction more common in young adults with type 2 vs type 1 diabetes

Findings from the SEARCH for Diabetes in Youth study suggest that diastolic dysfunction is prevalent among young adults with type 1 or type 2 diabetes, but those with type 2 diabetes have the highest risk.

05-13-2020 | Obesity | News

Genetic study backs weight loss to negate long-term childhood obesity risks

Findings from a genetic analysis support the notion that the harms of childhood obesity can be avoided by attaining a healthy BMI by adulthood.

04-01-2020 | Liraglutide (obesity) | News

Liraglutide for weight loss successful in obese adolescents

Liraglutide 3.0 mg boosts weight loss in obese adolescents receiving lifestyle therapy, show the findings of a phase 3 trial.

03-02-2020 | Diagnosis | News

Glucose tolerance test may be best for type 2 diabetes diagnosis in youth

An oral glucose tolerance test may identify youths with a more adverse cardiometabolic profile than a fasting plasma glucose test does, say researchers.

02-07-2020 | Pregnancy | News

Maternal diabetes, obesity may raise risk for neuropsychiatric disorders in children

Children born to mothers with diabetes and severe obesity have an elevated risk for developing neuropsychiatric disorders, researchers report.

01-08-2020 | Risk factors | News

Early puberty may raise type 2 diabetes risk in women

Earlier age at menarche is associated with an increased risk for type 2 diabetes and impaired glucose tolerance among women, and this association remains significant after adjustment for adiposity, suggest findings from a meta-analysis.

09-23-2019 | Children | EASD 2019 | News

RISE compares alpha, beta cells in youth vs adults with early type 2 diabetes

The failure of intensive medication to halt beta-cell decline in children with early type 2 diabetes occurs despite them having better baseline beta-cell and alpha-cell function than newly diagnosed adults, say the RISE researchers.